Tags

Type your tag names separated by a space and hit enter

[Cancer mortality in Chile: epidemiological considerations].
Rev Med Chil. 2001 Oct; 129(10):1195-202.RM

Abstract

Malignancies are the second most important cause of mortality in Chile, accounting for 21.8% of total deaths. In comparison with other causes, cancer mortality shows an upward trend with increasing mortality rates from 99 to 118 per 100.000 population in the period 1980-1998. The most important cancer locations are stomach, lung and prostate among men and gallbladder, stomach, breast and uterine cervix in women. According to present risks, the mean probability for a Chilean to die from cancer is 3.0% for stomach, 2.3% for prostate, 2.0% for lung, 1.7% for gallbladder, 1.6% for breast and 1.2% for uterine cervix cancer. Recent trends of cancer crude death rates are a matter of concern. During the period 1990-1998 a significant decrease of death rates was only noticed for uterine cervix cancers. On the other hand, important increases were observed for prostate, lung, gallbladder, colon and kidney cancers. If death rates are adjusted by age, an increased risk, not due to the population aging process, is noticed for prostate and to less extent for kidney, colon, skin and myeloma. The adjusted rates show a downward trend for uterine cervix, stomach, breast and esophagus cancer. Increasing cancer mortality is associated with diagnostic and therapeutic delays. Possible actions in screening programs are discussed.

Authors+Show Affiliations

Escuela de Salud Pública, Facultad de Medicina, Universidad de Chile. emedina@machi.med.uchile.clNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

spa

PubMed ID

11775349

Citation

Medina, E, and A M. Kaempffer. "[Cancer Mortality in Chile: Epidemiological Considerations]." Revista Medica De Chile, vol. 129, no. 10, 2001, pp. 1195-202.
Medina E, Kaempffer AM. [Cancer mortality in Chile: epidemiological considerations]. Rev Med Chil. 2001;129(10):1195-202.
Medina, E., & Kaempffer, A. M. (2001). [Cancer mortality in Chile: epidemiological considerations]. Revista Medica De Chile, 129(10), 1195-202.
Medina E, Kaempffer AM. [Cancer Mortality in Chile: Epidemiological Considerations]. Rev Med Chil. 2001;129(10):1195-202. PubMed PMID: 11775349.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Cancer mortality in Chile: epidemiological considerations]. AU - Medina,E, AU - Kaempffer,A M, PY - 2002/1/5/pubmed PY - 2002/2/2/medline PY - 2002/1/5/entrez SP - 1195 EP - 202 JF - Revista medica de Chile JO - Rev Med Chil VL - 129 IS - 10 N2 - Malignancies are the second most important cause of mortality in Chile, accounting for 21.8% of total deaths. In comparison with other causes, cancer mortality shows an upward trend with increasing mortality rates from 99 to 118 per 100.000 population in the period 1980-1998. The most important cancer locations are stomach, lung and prostate among men and gallbladder, stomach, breast and uterine cervix in women. According to present risks, the mean probability for a Chilean to die from cancer is 3.0% for stomach, 2.3% for prostate, 2.0% for lung, 1.7% for gallbladder, 1.6% for breast and 1.2% for uterine cervix cancer. Recent trends of cancer crude death rates are a matter of concern. During the period 1990-1998 a significant decrease of death rates was only noticed for uterine cervix cancers. On the other hand, important increases were observed for prostate, lung, gallbladder, colon and kidney cancers. If death rates are adjusted by age, an increased risk, not due to the population aging process, is noticed for prostate and to less extent for kidney, colon, skin and myeloma. The adjusted rates show a downward trend for uterine cervix, stomach, breast and esophagus cancer. Increasing cancer mortality is associated with diagnostic and therapeutic delays. Possible actions in screening programs are discussed. SN - 0034-9887 UR - https://www.unboundmedicine.com/medline/citation/11775349/[Cancer_mortality_in_Chile:_epidemiological_considerations]_ L2 - https://medlineplus.gov/cancerinchildren.html DB - PRIME DP - Unbound Medicine ER -